Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipients

Liver Transpl. 2022 Aug;28(8):1393-1396. doi: 10.1002/lt.26472. Epub 2022 May 9.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Viral
  • Antibody Formation
  • COVID-19* / prevention & control
  • Humans
  • Liver Transplantation* / adverse effects
  • RNA, Messenger
  • SARS-CoV-2 / genetics
  • Transplant Recipients
  • Vaccination

Substances

  • Antibodies, Viral
  • RNA, Messenger